Clinical trials show patients typically lose 510% of their starting body weight on semaglutide, and up to 1520% on tirzepatide
however, gastrointestinal adverse effects such as nausea, vomiting, and diarrhea are the most frequently reported, particularly during the initial treatment phase (Wilding et al., 2021
Alpha Lipoic Acid can lower blood glucose levels
This is particularly important if you take Mounjaro with insulin or sulfonylureas, requiring regular blood glucose monitoring and awareness of other symptoms like sweating, confusion, or dizziness
The results suggest that these drugs may have protective effects against cancer, but more research is needed